RhumbLine Advisers’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-54,543
| Closed | -$2.16M | – | 4397 |
|
|
2024
Q1 | $2.16M | Buy |
54,543
+10,822
| +25% | +$429K | ﹤0.01% | 1871 |
|
|
2023
Q4 | $833K | Buy |
43,721
+2,318
| +6% | +$44.2K | ﹤0.01% | 2363 |
|
|
2023
Q3 | $474K | Buy |
41,403
+1,977
| +5% | +$22.6K | ﹤0.01% | 2639 |
|
|
2023
Q2 | $405K | Buy |
39,426
+6,578
| +20% | +$67.6K | ﹤0.01% | 2823 |
|
|
2023
Q1 | $254K | Buy |
32,848
+6,615
| +25% | +$51.2K | ﹤0.01% | 2668 |
|
|
2022
Q4 | $193K | Buy |
26,233
+4,496
| +21% | +$33.1K | ﹤0.01% | 2799 |
|
|
2022
Q3 | $157K | Buy |
21,737
+1,333
| +7% | +$9.63K | ﹤0.01% | 2940 |
|
|
2022
Q2 | $174K | Buy |
+20,404
| New | +$174K | ﹤0.01% | 2967 |
|